RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shionogi & Co Stock

Shionogi & Co ROCE 2024

Shionogi & Co ROCE

0.14

Ticker

4507.T

ISIN

JP3347200002

WKN

855648

In 2024, Shionogi & Co's return on capital employed (ROCE) was 0.14, a 20.17% increase from the 0.11 ROCE in the previous year.

Shionogi & Co Aktienanalyse

What does Shionogi & Co do?

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Shionogi & Co's Return on Capital Employed (ROCE)

Shionogi & Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Shionogi & Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Shionogi & Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Shionogi & Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Shionogi & Co stock

What is the ROCE (Return on Capital Employed) of Shionogi & Co this year?

The ROCE of Shionogi & Co is 0.14 undefined this year.

How has the ROCE (Return on Capital Employed) of Shionogi & Co developed compared to the previous year?

The ROCE of Shionogi & Co has increased by 20.17% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Shionogi & Co?

A high Return on Capital Employed (ROCE) indicates that Shionogi & Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Shionogi & Co?

A low ROCE (Return on Capital Employed) can indicate that Shionogi & Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Shionogi & Co impact the company?

An increase in the ROCE of Shionogi & Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Shionogi & Co affect the company?

A decrease in ROCE of Shionogi & Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Shionogi & Co?

Some factors that can affect Shionogi & Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Shionogi & Co so important for investors?

The ROCE of Shionogi & Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Shionogi & Co take to improve the ROCE?

To improve the ROCE, Shionogi & Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 170 JPY . This corresponds to a dividend yield of about 2.56 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 183.81 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 2.56 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 183.81 JPY are expected. This corresponds to a dividend yield of 2.76 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/1/2024 amounting to 85 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Shionogi & Co in the year 2023?

In the year 2023, Shionogi & Co distributed 150 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shionogi & Co

Our stock analysis for Shionogi & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shionogi & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.